A microRNA meta-signature for pancreatic ductal adenocarcinoma

Expert Review of Molecular Diagnostics

Volumn 14, Issue 3, 2014, Pages 267-271

  Frampton, Adam E ^a   Giovannetti, Elisa ^b   Jamieson, Nigel B ^c   Krell, Jonathan ^a   Gall, Tamara Mh ^a   Stebbing, Justin ^a   Jiao, Long R ^a   Castellano, Leandro ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

biomarkers; diagnostic; meta signature; miRNA; pancreatic ductal adenocarcinoma; prognostic

Indexed keywords

CADHERIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 100; MICRORNA 143; MICRORNA 148A; MICRORNA 155; MICRORNA 21; MICRORNA 217; MICRORNA 221; MICRORNA 23A; MICRORNA 31; MICRORNA 375; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACTIN FILAMENT; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; DOWN REGULATION; FOCAL ADHESION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; META ANALYSIS; MICROARRAY ANALYSIS; NOTE; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; UPREGULATION; WNT SIGNALING PATHWAY;

CARCINOMA, PANCREATIC DUCTAL; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896947251     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2014.893192     Document Type: Note

References (28)

1. Ma M-Z, Kong X, Weng M-Z, et al. Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: metaanalysis, experimental validation and clinical significance. J Exp Clin Cancer Res 2013; 32(1):71
2. Kolde R, Laur S, Adler P, Vilo J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 2012; 28(4):573-80
3. Rhodes DR, Yu J, Shanker K, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004;101(25): 9309-14
4. Vosa U, Vooder T, Kolde R, et al. Meta-analysis of microRNA expression in lung cancer. Int J Cancer 2013;132(12): 2884-93
5. Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012;491(7424):399-405
6. Giovannetti E, van der Velde A, Funel N, et al. High-throughput microRNA (miRNAs) arrays unravel the prognostic role of mir-211 in pancreatic cancer. PLoS One 2012;7(11):e49145
7. Frampton AE, Castellano L, Colombo T, et al. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology 2014;146(1): 268-77; e218
8. Giovannetti E, Funel N, Peters GJ, et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010;70(11):4528-38
9. Hwang JH, Voortman J, Giovannetti E, et al. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One 2010;5(5):e10630
10. Moriyama T, Ohuchida K, Mizumoto K, et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 2009; 8(5):1067-74
11. Hamilton MP, Rajapakshe K, Hartig SM, et al. Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nat Commun 2013;4:2730
12. Kadera BE, Li L, Toste PA, et al. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS One 2013;8(8): e71978
13. Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007;26(30): 4442-52
14. Yihui M, Shuangni Y, Wugan Z, et al. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett 2010;298(2):150-8
15. Zhang Y, Li M, Wang H, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 2009;33(4): 698-709
16. Jamieson NB, Morran DC, Morton JP, et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res 2012;18(2):534-45
17. Ohuchida K, Mizumoto K, Kayashima T, et al. MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Ann Surg Oncol 2011;18(8):2381-7
18. Chhabra R, Adlakha YK, Hariharan M, et al. Upregulation of miR-23a-27a-24- 2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells. PLoS One 2009; 4(6):e5848
19. Li X, Liu X, Xu W, et al. c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem 2013;288(25):18121-33
20. Acunzo M, Romano G, Palmieri D, et al. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proc Natl Acad Sci USA 2013;110(21):8573-8
21. Zheng H, Li W, Wang Y, et al. miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer. Carcinogenesis 2014;35(1):173-83
22. von Burstin J, Eser S, Paul MC, et al. E-Cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 2009;137(1): 361-71; e365
23. Gall TM, Frampton AE. Gene of the month: E-cadherin (CDH1). J Clin Pathol 2013;66(11):928-32
24. Ma Y, Yu S, Zhao W, et al. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett 2010; 298(2):150-8
25. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297(17): 1901-8
26. Frampton AE, Gall TM, Giovannetti E, et al. Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical use. Expert Rev Mol Diagn 2013;13(4):325-9
27. Farrell JJ, Toste P, Wu N, et al. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. Am J Gastroenterol 2013; 108(8):1352-9
28. Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 2014;311(4):392-404